Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? - Wikidata - awgldk - TriplyDB

Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?

Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?

http://www.wikidata.org/entity/Q37280719

about

Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study Glyoxalase 1-419C>A variant is associated with oxidative stress: implications in prostate cancer progression Co-occurring gland angularity in localized subgraphs: predicting biochemical recurrence in intermediate-risk prostate cancer patients Evidence that selenium binding protein 1 is a tumor suppressor in prostate cancer Emphasizing the role of Wnt5a protein expression to predict favorable outcome after radical prostatectomy in patients with low-grade prostate cancer Contemporary risk profile of prostate cancer in the United States.Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.Methylation profiling identified novel differentially methylated markers including OPCML and FLRT2 in prostate cancer Establishment and genomic characterization of mouse xenografts of human primary prostate tumors.The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era.An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation.Mediterranean Diet Score and prostate cancer risk in a Swedish population-based case-control study.Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria.Plasma insulin-like growth factor 1 is positively associated with low-grade prostate cancer in the Health Professionals Follow-up Study 1993-2004.Identification of a novel prostate cancer biomarker, caveolin-1: Implications and potential clinical benefit.Blood-based biomarkers of aggressive prostate cancer.Gleason 6 Prostate Cancer: Translating Biology into Population Health.Immunohistochemical expression of BRCA1 and lethal prostate cancer.Calcium and phosphorus intake and prostate cancer risk: a 24-y follow-up study.CXCL12 Modulates Prostate Cancer Cell Adhesion by Altering the Levels or Activities of β1-Containing Integrins.mRNA expression signature of Gleason grade predicts lethal prostate cancer GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer.Genome-wide association study of prostate cancer mortality Metabolic alterations and targeted therapies in prostate cancer.Parameters of prostate cancer at contrast-enhanced ultrasound: correlation with prostate cancer risk.The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer Coffee consumption and risk of nonaggressive, aggressive and fatal prostate cancer--a dose-response meta-analysis.Tumor expression of adiponectin receptor 2 and lethal prostate cancer Prediagnostic Obesity and Physical Inactivity Are Associated with Shorter Telomere Length in Prostate Stromal Cells.Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study Statin use and risk of prostate cancer: Results from the Southern Community Cohort Study.Molecular characterization of Gleason patterns 3 and 4 prostate cancer using reverse Warburg effect-associated genes Lycopene, Tomato Products, and Prostate Cancer Incidence: A Review and Reassessment in the PSA Screening Era.Total antioxidant intake and prostate cancer in the Cancer of the Prostate in Sweden (CAPS) study. A case control study.Increased prostate cancer specific mortality following radical prostatectomy in men presenting with voiding symptoms-A whole of population study.Long-term aspirin use and the risk of total, high-grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988-2006.Dietary fatty acid intake and prostate cancer survival in Örebro County, Sweden.Identification of threshold prostate specific antigen levels to optimize the detection of clinically significant prostate cancer by magnetic resonance imaging/ultrasound fusion guided biopsy.Identifying in vivo DCE MRI markers associated with microvessel architecture and gleason grades of prostate cancer Whole-lesion apparent diffusion coefficient metrics as a marker of percentage Gleason 4 component within Gleason 7 prostate cancer at radical prostatectomy.

P2860

Q24650442-650DA8CE-719A-4CC1-B394-7E6027AEBC75 Q28533215-D086146F-FAE3-4F55-8285-341B30EEECA8 Q28539180-E113AEEC-FA2D-4D90-B680-7DCE39496A8C Q28547310-5176CB55-D22D-4216-96F0-63682A517812 Q28709995-CED6F5E2-0923-4473-BA3F-87145688CD63 Q30490241-AF093446-6164-4365-BDC1-E846726D7CC7 Q30664726-B54D2D06-4F7B-4DB4-A06F-ADEC2E6F2584 Q30764223-1A2B4608-3734-404E-B82D-CB7522732916 Q33745240-11F7C1A7-CDC2-4F63-92BE-5614B088837D Q34042937-D79AE7BD-A402-4D75-91E9-37C2DA6FC349 Q34082390-26E52ED8-47EF-4FE7-8C91-CB8131BC6CD9 Q34126042-2320E4B6-D8C8-4EB1-A102-B047DEC420F2 Q34148722-205DD519-6B37-4917-9918-1F23DF3E1903 Q34166384-2A3F6FC0-1B51-43BA-B470-F8EA8D2239B9 Q34417941-32271FCC-13C4-4DE3-B2F9-C3C03A37B3F0 Q34448347-628CAF21-B185-4649-A57D-107F9D4C7EF8 Q34470640-6FF32F11-F77F-48B6-849C-6F5CF2DD8BFB Q34626692-FB2919C2-0A53-4C87-BEA5-A728D6E3A06F Q34706595-0A4CBE0C-D178-40D4-A457-E6DE6359EB24 Q34786176-D6D3D2E3-B3E0-4F72-92CA-1F5886F26581 Q35023464-B1F26949-E632-4550-8988-3E2BC907BD8B Q35322421-CA3D197C-F148-4AA7-A205-B15F8E73A3BD Q35399770-0700477A-BBF7-41B8-B2B5-BFC9C760B6F5 Q35401667-094C3242-11FD-42E2-9738-F991767FF1B5 Q35480765-2DF2E49D-C48F-4E67-813C-0DB1E78F9448 Q35582540-085D624D-BCEB-4428-A525-86DE8B1CC706 Q35611822-B686479A-A940-49B2-BAB8-BA7DCF1C8D4D Q35784565-9643398A-1FD5-4B11-B08C-9626CAC2D4F5 Q35920675-762D7A17-38D9-4C1D-A00E-4E7797F94F4A Q35925515-E69515A8-951D-4978-9314-FD5CA198BC4B Q35952232-311B8783-9973-41A9-BF88-1BF7EEEA77D8 Q36010440-3F41BA10-C607-40FC-A383-52350960834B Q36011585-1C66FC60-3F3D-4D58-BB15-F07977EEBCAB Q36072901-6D78EE53-9765-4BB4-82FF-DA19549516F0 Q36106227-12B6D32C-2022-4145-B8F3-3A89A4BFEECF Q36241844-C52DC901-0755-4D66-BAFB-9EF8E201DF1F Q36379958-5610503B-7847-41CC-9174-1D6E6EC73A73 Q36386904-B8B68001-25B5-48FF-872F-9330F16DE354 Q36404493-0E27E2C5-1F75-4E50-93A3-8E70851A4F2E Q36417640-18AC8585-9948-42D9-9B4E-25B5E1A2FCED

P2860

Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?

http://www.wikidata.org/entity/Q37280719

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?

@en

Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?

@nl

type

label

Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?

@en

Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?

@nl

prefLabel

Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?

@en

Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?

@nl

P1433

Q37280719-7EBDBC33-3CCC-4602-9AAB-7754B14A9C55

P1476

Q37280719-404637D9-821A-431B-8903-7EDA8149355B

P2093

Q37280719-362E3FB6-F44E-4DC1-A995-687261C96062

Q37280719-74A85850-5E69-41AA-8C10-5DA2FB32DABD

Q37280719-7F333B1D-2921-4448-BD39-62EE91673D76

Q37280719-A6470261-2D7A-4FEE-A40B-3FB6484B27E3

Q37280719-CB127D13-262D-42B3-9C7F-C70926925049

P2860

Q37280719-2825649E-343D-4905-BDFA-92E9269F11D6

Q37280719-29EFCD94-2F3D-4CDD-80B1-A9D5C9E10736

Q37280719-3E94B3C5-96B2-420F-AB5A-4664A9DBF7A4

Q37280719-3F6C0B91-1837-4BA7-825C-068FF91E0806

Q37280719-4606F5AE-F909-438F-A6F1-FEE603879BC5

Q37280719-57977F65-CBBC-459A-A695-0E4DB11A516E

Q37280719-58A16E01-E327-457B-9CCB-C3315F4C5EE6

Q37280719-6E601C49-3493-4D9A-AB21-EFEBA73C35DF

Q37280719-758C7547-F1ED-49F8-A1B9-352C0940727A

Q37280719-8157F0A3-9939-455B-9CF4-16DD4EF22955

P304

Q37280719-B8C6A41B-F2AF-4E50-BE68-0440D1D03CCE

P31

Q37280719-ABEF1405-CB0E-4C86-8009-5F54B7F02082

P356

Q37280719-DBBFCA4B-78F5-40A2-9451-360C1430520B

P407

Q37280719-E62E0A56-2483-43D6-945B-0EB6360AF2CE

P433

Q37280719-7A4F2AB7-9494-4FAA-AE50-7B234030DDD9

P478

Q37280719-BEF96E3C-B9BF-4B6F-8FE5-8CA0562D4EF8

P50

Q37280719-022D59CD-9C9E-4159-8901-B2959F26D7FE

Q37280719-0A271149-766A-4AB1-B70D-B48E59FEDB83

Q37280719-1EA789F6-AA9A-4665-A808-F83D3C632AE8

Q37280719-2CD19131-62E4-4C88-A895-1CD31980956A

Q37280719-4F212B0E-1E67-4EE6-815D-3185B5029C5C

Q37280719-62C81355-9100-48CC-8437-72D2D574BFF1

Q37280719-BCEEBABE-5046-4F0B-98E4-78B5AFD458A0

Q37280719-E0409889-A09C-4B79-982F-30FF062D42BF

P577

Q37280719-E3CC0D89-A2BB-4B2A-9B74-E9B097BD1F70

P5875

Q37280719-4412B489-9679-4519-AEEC-D3746E82E271

P698

Q37280719-1C37482B-908E-4624-89DF-60ABA48DE9A0

P932

Q37280719-5EDDB266-719A-4806-9EC5-AFAB71F7E1A0

P356

JCO.2008.20.4669

P1433

Journal of Clinical Oncology

P1476

Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?

@en

P2093

Anna S Eisenstein

http://www.w3.org/2001/XMLSchema#string

Jennifer A Sinnott

http://www.w3.org/2001/XMLSchema#string

Jing Ma

http://www.w3.org/2001/XMLSchema#string

Michelangelo Fiorentino

http://www.w3.org/2001/XMLSchema#string

Sven Perner

http://www.w3.org/2001/XMLSchema#string

P2860

Final report on the aspirin component of the ongoing Physicians' Health Study

Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years: is there evidence for systematic upgrading?

Natural history of progression after PSA elevation following radical prostatectomy.

Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials.

Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen.

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease.

The Gleason score shift: score four and seven years ago.

Risk stratification of men with Gleason score 7 to 10 tumors by primary and secondary Gleason score: results from the SEARCH database.

Histologic grading of prostate cancer: a perspective.

Nomograms for prostate cancer.

P304

3459-3464

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2008.20.4669

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Edward Giovannucci

Stephen P. Finn

Jennifer R Stark

Lorelei A Mucci

Meir J Stampfer

P577

2009-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24419182

http://www.w3.org/2001/XMLSchema#string

P698

19433685

http://www.w3.org/2001/XMLSchema#string

P932

2717753

http://www.w3.org/2001/XMLSchema#string